Orforglipron: The Weight-Loss Pill Fast Tracked by the FDA
Update: 2025-09-16
Description
Obesity Pill Revolution? Eli Lilly's orforglipron could be fast-tracked by the FDA, potentially slashing review times and costs for weight-loss treatment. Find out how this game-changing pill, showing 12%+ weight loss in trials, could generate billions and challenge pricey injectables, offering hope for affordable solutions in the obesity crisis.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
